SAMUEL HAMILTON: Open Payments
NPI 1598481723 · ELKHORN CITY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,182 in 65 payments from 12 companies in 2025. Trend: 2023 $265 · 2024 $519 · 2025 $1,182
Food & beverage: $1,180Education: $1
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $271 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $251 |
| Otsuka America Pharmaceutical, Inc. | 15 | $244 |
| Indivior Inc. | 5 | $96 |
| ABBVIE INC. | 4 | $82 |
| Axsome Therapeutics, Inc. | 6 | $82 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $58 |
| Alkermes, Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: CAPLYTA, REXULTI, HETLIOZ, SUBLOCADE, VRAYLAR, Auvelity, FANAPT, ABILIFY ASIMTUFII.
Industry payments across KY — which companies pay providers there.
